Axitinib in the Metastic Treatment Renal Cancer

dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorHejzlarová Věracs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2018-09-25T12:18:33Z
dc.date.available2018-09-25T12:18:33Z
dc.date.issued2017cs
dc.format.extent0cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/31833
dc.language.isoczecs
dc.relation.ispartofseries0cs
dc.subjectrenal cancercs
dc.subjecttreatment toxicitycs
dc.subjectoverall survivalcs
dc.subjectsurvivalcs
dc.titleAxitinib in the Metastic Treatment Renal Canceren
dc.titleAxitinib V Léčbě Metastatického Renálního Karcinomucs
local.identifier.publikace5302
Files
Collections